Additional Metadata
Persistent URL dx.doi.org/10.1016/s2468-1253(18)30414-x, hdl.handle.net/1765/116366
Journal Lancet Gastroenterology & Hepatology
Rights no subscripiton
Citation
Boerekamps, A., De Weggheleire, A., van den Berk, G.E., Lauw, FN, Claassen, M.A.A, Posthouwer, D, … Rijnders, B.J.A. (2019). Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial. Lancet Gastroenterology & Hepatology, 4(4), 269–277. doi:10.1016/s2468-1253(18)30414-x